Determination of butyric acid dosage based on clinical and experimental studies – a literature review

Determination of butyric acid dosage based on clinical and experimental studies – a literature review

Short-chain fatty acids produced by bacteria living in the large intestine are the main energy substrate for the colonocytes. Butyric acid is used for the treatment and prevention of exacerbations of various gastrointestinal diseases: diarrhoea, intestinal inflammations, functional disorders, dysbio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tomasz Banasiewicz, Dorota Domagalska, Katarzyna Borycka-Kiciak, Grażyna Rydzewska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-06-01
Series:	Gastroenterology Review
Subjects:	butyrate irritable bowel syndrome dosage short-chain fatty acids
Online Access:	https://www.termedia.pl/Determination-of-butyric-acid-dosage-based-on-clinical-and-experimental-studies-a-literature-review,41,40722,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Butyric acid – a well-known molecule revisited
by: Katarzyna Borycka-Kiciak, et al.
Published: (2017-06-01)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
by: Konrad Lewandowski, et al.
Published: (2022-01-01)

Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine
by: Izabella Sall, et al.
Published: (2025-12-01)

Dose-dependent effects of apple pectin on alleviating high fat-induced obesity modulated by gut microbiota and SCFAs
by: Yuanyuan Zhao, et al.
Published: (2022-01-01)

Probiotics in irritable bowel syndrome – is the quest for the right strain over? Rapid review of existing guidelines and recommendations
by: Wojciech Marlicz, et al.
Published: (2021-12-01)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
by: Katarzyna Skrobisz, et al.
Published: (2019-09-01)

The specificity of ten non-digestible carbohydrates to enhance butyrate-producing bacteria and butyrate production in vitro fermentation
by: Jingjing Xu, et al.
Published: (2023-11-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Fermented-milk bacteria: role in intestinal peristalsis regulation
by: Yu. O. Shulpekova
Published: (2010-06-01)

Butyric Acid Modulates Gut Microbiota to Alleviate Inflammation and Secondary Bone Loss in Ankylosing Spondylitis
by: Ke You, et al.
Published: (2024-12-01)

Alterations of bile acid metabolism in patients with functional bowel disorders: a case-control study
by: Serhii Polishchuk, et al.
Published: (2023-11-01)

Precision biotic as an effective replacement of hydrolyzed yeast and butyrate in antibiotic free diets of broiler chickens raised under field conditions
by: C. Bortoluzzi, et al.
Published: (2025-02-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
by: A. A. Sheptulin
Published: (2022-01-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
by: Wenqian Yu, et al.
Published: (2025-02-01)

Propionic Acid-Producing Bacteria as Provocateurs of Anxiety and Depression? [Letter]
by: Prescott SL, et al.
Published: (2025-02-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Calculation of drug dosages : a work text /
by: Ogden, Sheila J., 1949-
Published: (2012)

The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis
by: Naohisa Yoshida, et al.
Published: (2025-01-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Metabolomics Biomarkers in Prediction of Sudden Infant Death Syndrome: The Role of Short Chain Fatty Acids
by: Maria Aslam, et al.
Published: (2025-01-01)

Effects of butyric acid and Protoxin probiotic in the feeding of Siberian sturgeon (Acipenser baerii)
by: Rasool Zare, et al.
Published: (2024-09-01)

Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy
by: Alexandra Laura Mederle, et al.
Published: (2025-01-01)

Microbiota from young mice counteracts susceptibility to age-related gout through modulating butyric acid levels in aged mice
by: Ning Song, et al.
Published: (2025-02-01)

Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome
by: Elif Tugba Tuncel, et al.
Published: (2025-01-01)

Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
by: A. Yu. Baranovsky, et al.
Published: (2024-01-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer
by: Linsheng Xu, et al.
Published: (2025-01-01)